Publications
Filters: First Letter Of Last Name is L [Clear All Filters]
“The practicality and sustainability of a community advisory board at a large medical research unit on the Thai-Myanmar border”, Health, vol. 05, no. 02, pp. 229-236, 2013.
, “Motivations and perceptions of community advisory boards in the ethics of medical research: the case of the Thai-Myanmar border”, BMC Medical Ethics, vol. 15, no. 1, p. 12, 2014.
, “Elimination of Plasmodium falciparum in an area of multi-drug resistance”, Malar J, vol. 14, p. 319, 2015.
, “Clinically uncomplicated Plasmodium falciparum malaria with high schizontaemia: a case report”, Malar J, vol. 7, p. 57, 2008.
, “A randomised, double-blind, placebo controlled trial of monthly versus second monthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria”, Antimicrob Agents Chemother, vol. 56, no. 3, pp. 1571-1577, 2012.
, “A randomised, double-blind placebo controlled trial of two different dosing regimens of dihydroartemisinin-piperaquine for intermittent preventive treatment of adults at high risk of malaria in Thailand”, in 59th Meeting of the American Society of Tropical Medicine and Hygiene, Washington DC, USA, 2010, vol. 83, p. 372.
, “Effects of malaria during pregnancy on infant mortality in an area of low malaria transmission”, Am J Epidemiol, vol. 154, no. 5, pp. 459-65, 2001.
, “The epidemiology of severe malaria in an area of low transmission in Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 91, no. 3, pp. 256-62, 1997.
, “Single day mefloquine-artesunate combination in the treatment of multi- drug resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 88, no. 2, pp. 213-7, 1994.
, “Early vomiting of mefloquine in children with malaria is not modified by the timing of antipyretic treatment”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 5, pp. 562-3, 1998.
, “Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 53, no. 5, pp. 522-5, 1995.
, “Beri-beri: the major cause of infant mortality in Karen refugees”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 97, no. 2, pp. 251-5, 2003.
, “Health care in refugee camps”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 2, pp. 129-30, 1998.
, “Treatment of vivax malaria on the western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 93, no. 4, pp. 433-8, 1999.
, “The epidemiology of malaria in a Karen population on the western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 2, pp. 105-11, 1996.
, “Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 1, pp. 45-9, 1998.
, “Naturally acquired immunity to vivax malaria”, Lancet, vol. 354, p. 162, 1999.
, “Mefloquine in infants and young children”, Annals of Tropical Paediatrics, vol. 16, no. 4, pp. 281-6, 1996.
, “Two patients with falciparum malaria and poor in vivo responses to artesunate”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 6, pp. 668-9, 1998.
, “Mefloquine for multidrug-resistant malaria”, Lancet, vol. 338. p. 1268, 1991.
, “Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia”, BMC Infect Dis, vol. 15, no. 1, p. 511, 2015.
, “Susceptibility of community-acquired pathogens to antibiotics in Africa and Asia in neonates--an alarmingly short review”, Trop Med Int Health, vol. 16, no. 2, pp. 145-51, 2011.
, “Cost-effectiveness of artesunate for the treatment of severe malaria”, Trop Med Int Health, vol. 14, no. 3, pp. 332-7, 2009.
, “Consensus recommendation on the treatment of malaria in Southeast Asia”, Southeast Asian Journal of Tropical Medicine and Public Health, vol. 29, no. 2, pp. 355-60, 1998.
, “Characterization of the Commercially-Available Fluorescent Chloroquine-BODIPY Conjugate, LynxTag-CQGREEN, as a Marker for Chloroquine Resistance and Uptake in a 96-Well Plate Assay”, PLoS One, vol. 9, no. 10, p. e110800, 2014.
, “Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria”, N Engl J Med, vol. 380, no. 3, pp. 229-241, 2019.
, “Thanaka (Limonia acidissima) and deet (di-methyl benzamide) mixture as a mosquito repellent for use by Karen women”, Medical and Veterinary Entomology, vol. 12, no. 3, pp. 295-301, 1998.
, “Major pitfalls in the measurement of artemisinin derivatives in plasma in clinical studies”, J Chromatogr B Analyt Technol Biomed Life Sci, vol. 876, no. 1, pp. 54-60, 2008.
, “Genetic mapping of fitness determinants across the malaria parasite Plasmodium falciparum life cycle”, PLoS Genet, vol. 15, no. 10, p. e1008453, 2019.
, “High density of ‘spiky’ excrescences covering the surface of an erythrocyte infected with Plasmodium malariae”, British Journal of Haematology, vol. 151, no. 1, pp. 1-1, 2010.
, “Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis”, Lancet Glob Health, vol. 7, no. 8, pp. e1031-e1045, 2019.
, “Methods for the field evaluation of quantitative G6PD diagnostics: a review”, Malaria Journal, vol. 16, no. 1, p. 361, 2017.
, “Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis”, PLoS Med, vol. 16, no. 12, p. e1002992, 2019.
, “Severe allergic reactions to oral artesunate: a report of two cases”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 95, no. 2, pp. 182-3., 2001.
, “Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum”, Antimicrob Agents Chemother, vol. 52, no. 7, pp. 2435-41, 2008.
, “Plasmodium vivax susceptibility to ferroquine”, Antimicrob Agents Chemother, vol. 54, no. 5, pp. 2228-30, 2010.
, “Evolution of antibiotic resistance is linked to any genetic mechanism affecting bacterial duration of carriage”, Proc Natl Acad Sci U S A, 2017.
, “Genome-wide identification of lineage and locus specific variation associated with pneumococcal carriage duration”, Elife, vol. 6, 2017.
, “Giemsa-Stained Wet Mount Based Method for Reticulocyte Quantification: A Viable Alternative in Resource Limited or Malaria Endemic Settings”, PLoS ONE, vol. 8, no. 4, p. e60303, 2013.
, “Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria”, Eur J Clin Pharmacol, 2008.
, “The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria”, Malar J, vol. 7, no. 1, p. 149, 2008.
, “Plasmodium-infected erythrocytes induce secretion of IGFBP7 to form type II rosettes and escape phagocytosis”, eLife, vol. 9, p. e51546, 2020.
, “A high-content phenotypic screen reveals the disruptive potency of quinacrine and 3',4'-dichlorobenzamil on the digestive vacuole of Plasmodium falciparum”, Antimicrob Agents Chemother, vol. 58, no. 1, pp. 550-8, 2014.
, “Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients”, PLoS One, vol. 12, no. 2. p. e0168780, 2017.
, “Glycophorin C (CD236R) mediates vivax malaria parasite rosetting to normocytes”, Blood, vol. 123, no. 18, pp. e100-e109, 2014.
, “Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar”, Wellcome Open Res, vol. 2, p. 81, 2017.
, , “Operational Performance of a Plasmodium falciparum Ultrasensitive Rapid Diagnostic Test for Detection of Asymptomatic Infections in Eastern Myanmar”, J Clin Microbiol, vol. 56, no. 8. 2018.
, “The role of early detection and treatment in malaria elimination”, Malar J, vol. 15, p. 363, 2016.
,